Login

Consolidated statements of assets and liabilities

In millions of USD, except per-share amounts
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
ASSETS
Investments—non-controlled/non-affiliated, at fair value (amortized cost of $382,268 and $311,762, respectively)
Cash, cash equivalents and restricted cash
Derivative assets, at fair value (Note 5)
Deferred offering costs
Receivable for investments sold
Due from Investment Adviser
Interest and other income receivable from investments
Receivable for issuance of common shares of beneficial interest
Prepaid expenses and other assets
Total assets
LIABILITIES
Secured borrowings (Note 6)
Payable for investments purchased
Derivative liabilities, at fair value (Note 5)
Interest and credit facility fees payable (Note 6)
Dividend payable (Note 8)
Incentive fees payable (Note 4)
Administrative service fees payable (Note 4)
Deferred financing costs payable
Deferred offering costs payable
Accrued organizational expenses
Deferred income
Other accrued expenses and liabilities
Total liabilities
NET ASSETS
Common shares of beneficial interest, $0.001 par value; unlimited shares authorized; 11,709,773 and 9,666,829 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively
Paid-in capital in excess of par value
Total distributable earnings (loss)
Total net assets
NET ASSETS PER SHARE (in dollars per share)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support